1,3-dinitrooxypropan-2-yl nitrate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

53 API Suppliers, 34 USDMF, 2 CEP/COS, 11 JDMF, 1 KDMF, 4 NDC API, 11 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

349 FDF Dossiers, 102 FDA Orange Book, 173 Europe, 19 Canada, 10 Australia, 4 South Africa, 41 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;SUBLINGUAL - 0.4MG/SPRAY, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.1MG/HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.2MG/HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.3MG/HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.4MG/HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.6MG/HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.8MG/HR, POWDER;SUBLINGUAL - 0.4MG/PACKET, TABLET;SUBLINGUAL - 0.3MG, TABLET;SUBLINGUAL - 0.4MG, TABLET;SUBLINGUAL - 0.6MG, OINTMENT;INTRA-ANAL - 0.4%, AEROSOL, METERED;SUBLINGUAL - 0.4MG/SPRAY, OINTMENT;TRANSDERMAL - 2%

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc, 18 SPI Pharma, 12 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 2 Boai NKY Pharmaceuticals Ltd, 12 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 8 Beneo, 6 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 7 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 1 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 29 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 18 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 31 Roquette, 2 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

98 Fillers, Diluents & Binders, 44 Direct Compression, 32 Taste Masking, 25 Coating Systems & Additives, 25 Thickeners and Stabilizers, 23 Granulation, 23 Lubricants & Glidants, 21 Film Formers & Plasticizers, 18 Disintegrants & Superdisintegrants, 17 Parenteral, 17 Co-Processed Excipients, 16 Chewable & Orodispersible Aids, 14 Topical, 12 Controlled & Modified Release, 9 Solubilizers, 8 Empty Capsules, 5 Emulsifying Agents, 4 Rheology Modifiers, 3 API Stability Enhancers, 3 Coloring Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 23 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 177 Finished Drug Prices, 2 Annual Reports

MARKET PLACE

26 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 1 US Exclusivities, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 5 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 208424 / DOSAGE - POWDER;SUBLINGUAL - 0.4MG/PACKET

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
NITROGLYCERIN(UNII: G59M7S0WS3) (NITROGLYCERIN - UNII:G59M7S0WS3)	NITROGLYCERIN	400ug

Inactive Ingredients

Ingredient Name	Allegis Pharmaceuticals, Inc.
ANHYDROUS DIBASIC CALCIUM PHOSPHATE(L11K75P92J)
ISOMALT(S870P55O2W)
MEDIUM-CHAIN TRIGLYCERIDES(C9H2L21V7U)
PEG-5 oleate(0240V77G50)
PEPPERMINT OIL(AV092KU4JH)

Drug Product Composition: 1,3-dinitrooxypropan-2-yl nitrate